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axons being more sensitive. The work of Keleman et al. suggested by these findings is that ubiquitination of
Comm (or of an associated protein) by DNedd4 allowsin the August 23 issue of Cell, as well as work by Myat
et al. (2002) and Georgiou and Tear (2002), supports a Comm to sequester Robo protein away from the cell
different model, in which the transient expression of surface by trafficking Robo from the Golgi to the endo-
Comm in contralaterally projecting neurons transiently somes. Interestingly, in Saccharomyces cerevisiae, po-
downregulates Robo signaling in these cells, permitting lyubiquitination of the transmembrane protein Gap1p
their axons to cross the midline once and only once. by the DNedd4 homolog Rsp5p prevents cell surface
Keleman et al. and Georgiou and Tear demonstrate accumulation of Gap1p by diverting it to the late endo-
that Comm function is required in CNS neurons for axon some (Roberg et al., 1997; Helliwell et al., 2001).
targeting. These authors also find that Comm is ex- These findings open several avenues of investigation.
pressed in a cell type-specific fashion in CNS neurons. Since regulation of Comm expression appears to dictate
Comm is expressed in contralaterally but not ipsilaterally whether an axon will cross the midline, it will be interest-
projecting neurons. Furthermore, Keleman et al. find that ing to discover what governs the timing and cell type
Comm expression is temporally regulated. Comm RNA specificity of Comm expression. Future experiments
is detected in contralaterally projecting neurons for a should also identify the cellular machinery responsible
brief period of time, while their axons are crossing the for sorting the Robo/Comm complex to the endosome
midline. These results suggest that the regulation of and determine whether there are additional targets of
Comm expression is critical for determining whether Comm. Also, given the evolutionary conservation of
axons cross the midline. Robo/Slit signaling from worms to humans, might this
Recent findings also shed light on the molecular mechanism for controlling Robo delivery similarly be
mechanism by which Comm regulates Robo protein ac- conserved? More generally, how widespread is the di-
cumulation. Keleman et al. and Myat et al. find that version of receptors via selective trafficking? Axon guid-
coexpression of Comm and Robo in tissue culture cells ance depends on dynamic temporal and spatial control
alters Robo’s subcellular localization. In the absence of of receptor signaling. These papers provide an elegant
Comm, Robo protein accumulates at the cell surface; example of how the nervous system has taken advan-
however, when both proteins are present, Robo colocal- tage of an ancient strategy to meet these demands.
izes with Comm to intracellular compartments, which
are probably late endosomes. As robust endocytosis of
Mark Rosenzweig and Paul GarrityRobo protein is detected only in Comm’s absence, this
Department of Biologychange in Robo localization likely results from altered
Massachusetts Institute of Technologyintracellular trafficking of Robo protein (Keleman et al.,
Cambridge, Massachusetts 021392002). Keleman et al. also demonstrate that Comm
needs to physically interact with Robo to affect Robo’s
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that Angiopoietin-2 (Ang2), a ligand for the endothelialDual Role of Ang2
Tie2 receptor tyrosine kinase, has a dual function inin Postnatal Angiogenesis the processes of postnatal angiogenesis and vascular
remodeling. Also, Ang2 signals are required for theand Lymphangiogenesis
proper development and function of the lymphatic
vessels.
The maturation of the vascular system and the adjust- Tissue metabolic needs dictate the blood vascular den-
ment of blood vessel density in tissues require the sity of each organ. Tissue hypoxia is a powerful inhibitor
opposing processes of vessel growth and regression. of the prolyl hydroxylases that control the ubiquitin-
mediated degradation of hypoxia-inducible transcrip-A new study in this issue of Developmental Cell shows
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A Model of the Action of Angiopoietins in An-
giogenesis and Lymphangiogenesis
Ang1 and platelet-derived growth factor
(PDGF)-BB are involved in periendothelial cell
(yellow) recruitment (arrow) and vessel stabi-
lization, while Ang2 destablilizes these inter-
actions in blood vessels (BV), allowing endo-
thelial cells to respond to the angiogenic
stimuli, such as VEGF. The results of Gale et
al. (2002) now show that Ang2 is involved in
recruitment of smooth muscle cells that are
required for the stability and proper function
of the collecting lymphatic vessels (LV). The
growth factor-receptor signaling pathways
are shown in this figure. Ang1 and Ang2 medi-
ate their signals via the Tie2 receptor, while
the various VEGFs bind to specific VEGF re-
ceptors and neuropilin (NRP) coreceptors. Via
these receptors they regulate the develop-
ment and function of the blood vessels
(VEGF, PlGF, VEGF-B, Ang1, and Ang2) and
lymphatic vessels (VEGF-C, VEGF-D, and
Ang2).
tion factors (HIF) (Kaelin, 2002). In hypoxic conditions, undergo angiogenesis, but they would regress by endo-
thelial cell apoptosis in the absence of VEGF (Holash etthe stabilized HIF complex reprograms gene expression,
including the increased expression of vascular endothe- al., 1999). Transgenic Ang2 expression in the embryonic
endothelia produces a similar phenotype as the deletionlial growth factor (VEGF), which stimulates the growth
of new blood vessels. After the formation of a primary of the Tie2 gene, supporting the view that Ang2 is an
antagonistic ligand (Maisonpierre et al., 1997). However,blood vessel network, the vasculature is remodeled by
the pruning of some of the newly formed vessels, so that the effects of Ang1 and Ang2 are often similar in various
cell culture models, suggesting that Ang2 is an agonisttissue oxygenation becomes matched with its metabolic
needs. Members of the VEGF family are key regulators of of Tie2 receptor signaling (Teichert-Kuliszewska et al.,
2001).blood and lymphatic vessel growth via their endothelial
cell-specific receptors (VEGFRs), while the Angiopoie- By genetic deletion of Ang2, Gale et al. (2002) now
provide further evidence that Ang2 is not redundant withtins (Ang) 1 and 2 have been shown to regulate vessel
stabilization via the Tie2 receptor (see Figure) (Jones et Ang1 but that it has unique functions. They show that the
developmentally programmed regression of the hyaloidal., 2001).
Data from several experimental systems have led to vasculature in the eye does not occur in the Ang2/
mice and that their retinal blood vessels fail to sprouta model in which Ang2 is presumed to destabilize blood
vessels by interfering with the Ang1-Tie2 signals and out from the central retinal artery. The development of
the retinal vasculature, which occurs in response to hyp-with endothelial-periendothelial cell interactions (Holash
et al., 1999). Ang2 upregulation, along with that of VEGF, oxia-driven VEGF expression (Alon et al., 1995), is clearly
linked to the regression of the hyaloid vascular system,is one of the first molecular changes in tumor angiogen-
esis, but, unlike VEGF, which is expressed in hypoxic as they share a common arterial supply from the optic
nerve head. While the reason for the failure of hyaloidtumor cells, Ang2 marks the neovascular endothelium
(Holash et al., 1999). Endothelial Ang2 could inhibit Tie2 vessel regression in the Ang2 knockout mice is not en-
tirely clear, these data make Ang2 the first growth factorsignals, thus promoting the sprouting of new vessels.
On the other hand, a very strong induction of Ang2 is shown to be dispensable for the proper development of
the blood vascular system, but necessary for postnatalseen in the regressing corpus luteum during a phase
of the menstrual cycle when VEGF levels have already angiogenesis and vascular remodeling. The blood vas-
cular phenotype of the Ang2 knockout mice would thendeclined and this expression is associated with vessel
regression (Maisonpierre et al., 1997). In the presence be consistent with the proposed model of Ang2 acting
as a factor that primes endothelial cells for angiogenesisof VEGF, the vessels destabilized by Ang2 would then
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by destabilizing interactions between endothelial cells of Ang1 and VEGF in blood vessel development. Thus,
and perivascular cells that induce blood vessel quies- Ang2 is the first endothelial cell-specific growth factor
cence. demonstrated to function in vessel formation or regres-
The second phenotype, observed in the Ang2/ mice, sion depending on the tissue context. Ang2 therefore
that Gale et al. (2002) report is more surprising. The becomes an interesting target for vascular gene therapy
Ang2 knockout mice displayed disorganization and hy- approaches intended to lead to blood vascular and lym-
poplasia of the intestinal and dermal lymphatic capillar- phatic vessel growth or regression.
ies. Their mesenteric-collecting lymphatic vessels were
not properly invested by smooth muscle cells (SMCs),
suggesting that, unlike in the blood vessels, Ang2 func-
Tanja Veikkola and Kari Alitalotions in lymphatic SMC recruitment. As the result of the
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sine kinase (Karkkainen et al., 2001).
The lymphatic vessels, which transport fluid and im-
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complexes (NPC) that are embedded within the nuclearNucleocytoplasmic Transport:
envelope. Import of cargo bearing the classic NLS motifMore Than the Usual Suspects can be broadly subdivided into the following steps. The
NLS import receptor, a heterodimer of importin- and
importin- proteins, initiates import by direct binding of
the NLS via the importin- subunit. The molecular details
A paper in the August 9 issue of Cell describes a novel of passage through the NPC are still poorly understood.
role for the nucleoporin Npap60/Nup50 as a soluble However, interactions between importin- and the phe-
cofactor in importin-:-mediated nuclear protein im- nylalanine-glycine (FG) repeats of several distinct NPC
port. These findings add a new dimension of complex- components, also referred to as nucleoporins, are of
ity to the current understanding of protein transport the essence. Within the nuclear interior, importin- en-
pathways. counters Ran, a small GTPase, in its GTP-bound state,
resulting in the formation of an importin-:RanGTP com-
plex and the concomitant release of importin- and NLSNucleocytoplasmic transport, a signal- and energy-
dependent process, takes place through nuclear pore cargo. Importin- is then bound by the nuclear export
